Xiaonan Shi

机构：Affiliated Hospital of Hebei University, First Affiliated Hospital of Zhengzhou University, Shandong Institute of Business and Technology, China Medical University · ORCID：0009-0001-0486-344X

发表论文 26 篇 · 总被引 490 次 · h-index 15

代表论文

• Long non-coding RNA UCA1 upregulation promotes the migration of hypoxia-resistant gastric cancer cells through the miR-7-5p/EGFR axis (2018 · Experimental Cell Research · 被引 62)
• Cancer-associated fibroblasts-stimulated interleukin-11 promotes metastasis of gastric cancer cells mediated by upregulation of MUC1 (2018 · Experimental Cell Research · 被引 53)
• Pirarubicin-loaded CalliSpheres® drug-eluting beads for the treatment of patients with stage III–IV lung cancer (2021 · Acta Radiologica · 被引 35)
• Transarterial chemoembolization of unresectable renal cell carcinoma with doxorubicin-loaded CalliSpheres drug-eluting beads (2022 · Scientific Reports · 被引 32)
• MiR-891a-5p as a prognostic marker and therapeutic target for hormone receptor-positive breast cancer (2020 · Journal of Cancer · 被引 25)
• FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma (2018 · Journal of Cancer Research and Clinical Oncology · 被引 25)